Interclean Shanghai

Antiestrogen Supplements Might Reduce Melanoma Risk

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...
According to an investigation published in Cancer Prevention Research, a journal of the American Association for Cancer Research, antiestrogen supplements may lower the risk of women with breast cancer developing melanoma. The Swiss Research Foundation against Cancer, a nonprofit group, funded the investigation. 
Data from 7,360 women who had breast cancer between 1980 and 2005 was examined by the team led by Dr. Christine Bouchardy, a professor at the University of Geneva and head of the Geneva Cancer Registry. 54% of the 7,360 women received antiestrogen therapy. 
The women were followed until 2008, during the follow-up period the investigators documented 34 cases of melanoma. The team discovered that the risk for developing melanoma was 60% higher among women who did not receive antiestrogen therapy than those who received it. 
As more focus is placed on the role estrogen plays in breast cancer, investigators are starting to wonder its role in other cancers. Bouchardy explains: "These data reinforce the hypothesis that estrogens play a role in melanoma occurrence." 
According to Bouchardy, this may be because estrogens are linked to raised levels of melanin and melanocytes production in human skin, which have been connected with early-stage melanoma. Although, Bouchardy cautioned against extensive antiestrogen supplementation to inhibit melanoma in the general population. 

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »